📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice. (2019)

First Author: Klein AF
Attributed to:  Advanced peptide-oligonucleotide therapy for Myotonic Dystrophy Type 1 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci128205

PubMed Identifier: 31479430

Publication URI: http://europepmc.org/abstract/MED/31479430

Type: Journal Article/Review

Volume: 129

Parent Publication: The Journal of clinical investigation

Issue: 11

ISSN: 0021-9738